What is the appropriate treatment for pink eye (conjunctivitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Pink Eye (Conjunctivitis)

For most cases of pink eye, treatment depends entirely on the underlying cause: bacterial conjunctivitis responds to topical antibiotics (though mild cases often resolve without treatment), viral conjunctivitis requires only supportive care, and allergic conjunctivitis needs topical antihistamines with mast-cell stabilizers. 1

Initial Assessment: Determining the Cause

The key to appropriate treatment is distinguishing between bacterial, viral, and allergic etiologies:

  • Bacterial conjunctivitis typically presents with mucopurulent discharge causing the eyelids to be matted shut upon waking, lacks itching, and has no prior history of conjunctivitis 2
  • Viral conjunctivitis usually presents with watery discharge, preauricular lymphadenopathy, and follicular reaction on the conjunctiva 3, 4
  • Allergic conjunctivitis is characterized by intense itching as the most consistent symptom, often with concurrent allergic rhinitis or asthma 5, 2

Bacterial Conjunctivitis Treatment

Mild to Moderate Cases

Observation without antibiotics is acceptable for mild bacterial conjunctivitis in immunocompetent adults, as approximately 64% of cases resolve spontaneously within 6-10 days. 1, 6

However, if you choose to prescribe antibiotics (to shorten symptom duration and allow faster return to work/school):

  • Fourth-generation fluoroquinolones (moxifloxacin 0.5% or gatifloxacin) three to four times daily for 5-7 days are preferred first-line agents due to broad gram-positive coverage 1, 6
  • Alternative options when fluoroquinolones are unavailable include ofloxacin 0.3%, gentamicin, or tetracycline four times daily 1
  • No single topical antibiotic has demonstrated superiority for uncomplicated cases; choice should be based on convenience, cost, and local resistance patterns 1, 6
  • Topical antibiotics provide earlier clinical remission (68.2% cure rate versus 55.5% with placebo by days 4-9) 6

Special Populations Requiring Different Management

  • Contact lens wearers: Use fourth-generation fluoroquinolones due to risk of Pseudomonas infection 1
  • Nursing home residents or suspected MRSA: Consider compounded topical vancomycin if no improvement within 48-72 hours, as MRSA isolates are typically resistant to fluoroquinolones but susceptible to vancomycin 1, 6
  • Neonates: Immediate ophthalmology referral is mandatory, as systemic treatment coordinated with a pediatrician is required 6

Sexually Transmitted Disease-Related Conjunctivitis

Gonococcal conjunctivitis requires systemic antibiotic therapy in addition to topical treatment:

  • Ceftriaxone 1 g IM single dose plus azithromycin 1 g oral single dose 1
  • Adjunctive saline lavage for comfort 1
  • Daily ophthalmologic monitoring is mandatory until resolution to prevent corneal perforation 1
  • Obtain conjunctival cultures and Gram staining before initiating therapy 1

Chlamydial conjunctivitis mandates systemic therapy:

  • Azithromycin 1 g orally single dose OR doxycycline 100 mg twice daily for 7 days in adults 1
  • Erythromycin 50 mg/kg/day divided every 4 hours for 14 days in infants 1
  • Topical therapy adds no benefit to systemic treatment 1
  • Re-evaluation after completion is essential because treatment failure occurs in up to 19% of cases 1
  • In children with gonococcal or chlamydial conjunctivitis, consider sexual abuse and arrange appropriate safeguarding measures 1

Alternative When Antibiotics Are Unavailable

  • A 1.25% povidone-iodine ophthalmic solution can be used as an effective alternative to topical antibiotics in resource-limited settings 1

Viral Conjunctivitis Treatment

Topical antibiotics provide no clinical benefit in viral conjunctivitis and should be avoided to reduce the risk of adverse effects and antimicrobial resistance 1, 6

Supportive Care Measures

  • Refrigerated preservative-free artificial tears four times daily to dilute viral particles and inflammatory mediators 6
  • Cold compresses to closed eyelids for comfort 6
  • Topical antihistamines for symptomatic relief of itching 6
  • Strict hand hygiene with soap and water is essential to prevent transmission 1, 6

Herpes Simplex Virus (HSV) Conjunctivitis

HSV conjunctivitis requires specific antiviral treatment:

  • Topical ganciclovir 0.15% gel OR topical trifluridine 1% solution 6
  • Oral antivirals (acyclovir, valacyclovir, or famciclovir) may also be used 6
  • Topical corticosteroids are absolutely contraindicated in HSV conjunctivitis as they potentiate infection 6

Adenoviral Conjunctivitis

  • No proven effective treatment for eradication exists 6, 4
  • Topical corticosteroids may be considered only in severe cases with marked chemosis, lid swelling, epithelial sloughing, or membranous conjunctivitis, but require close monitoring for elevated intraocular pressure and cataract 5, 6

Allergic Conjunctivitis Treatment

Second-generation topical antihistamines with mast-cell stabilizing properties are first-line therapy for allergic conjunctivitis 5, 6

Treatment Algorithm

  1. First-line: Topical antihistamine/mast-cell stabilizers (e.g., olopatadine, ketotifen) 5, 6
  2. Adjunctive measures: Cold compresses, refrigerated artificial tears, sunglasses as allergen barrier, avoiding eye rubbing 5
  3. Second-line: If symptoms persist, add a brief 1-2 week course of low side-effect profile topical corticosteroids (fluorometholone, rimexolone, or loteprednol) with monitoring of intraocular pressure 5, 6

Important Considerations

  • Chronic use of vasoconstrictor agents can cause rebound vasodilation once stopped 5
  • Oral antihistamines may worsen dry eye syndrome and actually exacerbate allergic conjunctivitis 5, 6
  • Concomitant use of cooled artificial tears may alleviate coexisting tear deficiency 5

Red-Flag Signs Requiring Immediate Ophthalmology Referral

Any of the following warrants urgent referral 1:

  • Decreased visual acuity
  • Moderate-to-severe ocular pain
  • Profuse purulent discharge (suggesting gonococcal infection)
  • Corneal involvement (opacity, infiltrate, ulcer)
  • Conjunctival scarring or membrane formation
  • Lack of improvement after 3-4 days of appropriate therapy
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised status
  • Neonatal conjunctivitis

Follow-Up Strategy

  • Routine bacterial conjunctivitis: Return for review in 3-4 days if symptoms have not improved 1
  • Gonococcal conjunctivitis: Daily visits until complete resolution 1
  • Chlamydial conjunctivitis: Reassess after therapy completion due to potential 19% failure rate 1
  • Patients may resume work or school 24-48 hours after initiating antibiotic therapy if symptoms are improving 1, 7

Critical Pitfalls to Avoid

  • Never use topical corticosteroids in HSV conjunctivitis without antiviral coverage, as they potentiate viral replication and can cause corneal perforation 6
  • Avoid indiscriminate use of topical antibiotics or corticosteroids, as antibiotics can induce toxicity and corticosteroids can prolong adenoviral infections 5, 6
  • Do not use combination antibiotic-steroid drops (e.g., Tobradex) unless viral etiology has been definitively excluded, particularly HSV or adenovirus 6
  • Delayed referral for gonococcal conjunctivitis can lead to corneal perforation within 24 hours 6
  • Failure to consider sexual abuse in children with gonococcal or chlamydial conjunctivitis can have serious consequences 6

References

Guideline

Evidence‑Based Management of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Research

Viral Conjunctivitis.

Viruses, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment for Conjunctivitis-Otitis Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.